166 related articles for article (PubMed ID: 12789737)
1. Thromboprophylaxis in patients undergoing total hip replacement.
Brenkel IJ; Cook RE
Hosp Med; 2003 May; 64(5):281-7. PubMed ID: 12789737
[TBL] [Abstract][Full Text] [Related]
2. [Standards and perspectives for thromboembolism prophylaxis].
Rader CP
Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
[TBL] [Abstract][Full Text] [Related]
3. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
4. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
Schousboe JT; Brown GA
J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
[TBL] [Abstract][Full Text] [Related]
7. Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
Kwong LM
J Arthroplasty; 2005 Jun; 20(4 Suppl 2):12-4. PubMed ID: 15991121
[TBL] [Abstract][Full Text] [Related]
8. [Prolonged postoperative thromboprophylaxis--current state of knowledge].
Bergqvist D
Lakartidningen; 2002 Mar; 99(13):1461-3. PubMed ID: 11989357
[TBL] [Abstract][Full Text] [Related]
9. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
[TBL] [Abstract][Full Text] [Related]
10. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
An VV; Phan K; Levy YD; Bruce WJ
J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
13. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
Colwell CW
Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with ximelagatran in orthopaedic surgery.
Eriksson B
Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
Imperiale TF; Speroff T
JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
[TBL] [Abstract][Full Text] [Related]
18. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic disease in hip replacement surgery.
Salvati E; Gonzales Della Valle A; Zoppi A; Pavone V
Chir Organi Mov; 2005; 90(3):209-28. PubMed ID: 16681100
[TBL] [Abstract][Full Text] [Related]
20. Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.
Jones CW; Spasojevic S; Goh G; Joseph Z; Wood DJ; Yates PJ
J Arthroplasty; 2018 Jan; 33(1):224-229. PubMed ID: 28869115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
